FDA NDC Directory · JSON-LD · Markdown

TAVALISSE

NDC 71332-002 · HUMAN PRESCRIPTION DRUG · TABLET

Generic nameFOSTAMATINIB
Labeler / ManufacturerRigel Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA209299
Dosage form / routeTABLET · ORAL
Active ingredientsFOSTAMATINIB (150 mg/1)
Marketing started20180509
Package count1

External sources

Source: openFDA. Public-domain (CC0).